XML 23 R4.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Grant revenue $ 4,006,510 $ 9,737,974
Operating expenses:    
Research and development 21,817,072 18,798,343
General and administrative 10,484,315 9,166,762
Total operating expenses 32,301,387 27,965,105
Loss from operations (28,294,877) (18,227,131)
Other income (expense):    
Other expense (8,327) (991)
Interest income 1,336,837 1,937,427
Total other income, net 1,328,510 1,936,436
Net loss $ (26,966,367) $ (16,290,695)
Per share information:    
Net loss per share of common stock, basic and diluted (in dollars per share) $ (2.98) $ (2.02)
Weighted average shares outstanding, basic and diluted (in shares) 9,041,760 8,073,155
Net loss:    
Net unrealized (loss) gain on marketable securities $ (50,381) $ 56,197
Total comprehensive loss $ (27,016,748) $ (16,234,498)